2023 Year End Press Briefing
Ref: Second Term Resumption speech (January 4, 2023) https://www.nafdac.gov.ng/second-term-resumption-speech-continuation-of-transformative-leadership-of-nafdac/ HIGHLIGHTS OF 2023 ACTIVITIES *Reorganization of Top Management Continual efforts to strengthen the regulatory and operational efficiency of the Agency, some Directors and other Officers were redeployed. * Hundreds of Staff Training in all regulatory activities (Few Examples) https://www.nafdac.gov.ng/sustainable-healthcare-development-workshop-on-local-manufacturing-of-apis-and-excipients/ * ZONAL SENSITIZATION CAMPAIGNS IN COLLABORATION […]
DG’s Remarks on the WHO Prequalification of NAFDAC’s Central Drug Control Laboratory (CDCL), Yaba
Protocol The National Agency for Food and Drug Administration and Control (NAFDAC) is delighted to announce a momentous achievement for the Central Drug Control Laboratory (CDCL) in Yaba, Lagos State, Nigeria. The World Health Organization (WHO) has officially granted WHO Prequalification Status to the CDCL, signifying a milestone in its dedication to ensuring the safety […]
Public Alert No. 036/2023 – Alert on Counterfeit Meronem 1g Injection circulating in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying Healthcare providers and the public that one batch of counterfeit Meronem 1g Injection has been purchased in Nigeria. The Marketing Authorization Holder (MAH) Pfizer reported the incident as received through a patient notification platform, concerning a suspicious park of Meronem 1g injection […]
The Positive Impact of Global Fund and Other Partners on NAFDAC’s Regulatory System Strengthening
The National Agency for Food and Drug Administration and Control (NAFDAC), mandated for safeguarding public health by ensuring that food and drug products made available to the public are safe, effective, and of good quality, is proud to announce the significant strides it has made in enhancing the safety and quality of pharmaceutical products in […]
Public Alert No. 035/2023 -Alert on Recall One lot of Growlyn Drops 50 ml in Abu Dhabi
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the United Arab Emirate Ministry of Health and Prevention (MOHAP) in Abu Dhabi issued a safety recall on Growlyn Drops 50ml manufactured by Aeon Formulations Pvt. Ltd., India. Laboratory analysis conducted on the product by MOHAP Quality Control Laboratory […]
Public Alert No. 034/2023 -Alert on Recall of G Fuel brand Energy Drinks due to High Levels of Caffeine
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Netherlands Food and Consumer Product Safety Authority (NVWA) and the Canadian Food Inspection Agency (CFIA) announced the recall of G Fuel brand Energy Drinks by T&E Imports and GPAE Trading Corp due to high levels of caffeine. Risk […]
Public Alert No. 33/2023 – Alert on the Ban of Sheesha Beauty Cream and Dona White Extra Whitening Lotion by the EU due to Mercury content
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the ban of Sheesha Beauty Cream and Dona White Extra Whitening Lotion by the EU. The products were tested against European standards and did not comply with the Cosmetic Products Regulation as they are said to contain mercury which […]
Public Alert No. 032/2023 – Alert on Parallel Importation of Novartis Brands
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of an observed parallel importation of some Novartis Prescription-Only-Medicines (POM) brands. The Ports Inspection Directorate of the Agency observed increased incidents of seizure of unregistered Novartis brands of some Prescription-Only-Medicines (POM) at the Murtala Mohammed International Airport, Ikeja, Lagos between […]
Keynote Speech by Prof. Mojisola Christiana Adeyeye on Fighting the Scourge of Illicit Trade in the Pharma Industry: The Role Of Communication
Protocol It is a great pleasure and honour for me to give this keynote speech on the 21st NECCI PR Roundtable. The topic of this address, “Fighting the scourge of illicit trade in the pharma industry: the role of communication” is very apt considering the expeditious need to promote local manufacturing of Active Pharmaceutical Ingredients […]
Public Alert No.31/2023 – Important Safety Communication on Abbott Diagnostics Medical Device
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers that Abbott has identified that some lots of m-PIMA HIV-1/2 VL do not meet performance claims for HIV-1 group O and HIV-1 group M and N throughout the claimed shelf life. This was discovered through an internal stability monitoring program. […]
